SCHEMBL4172587

SCHEMBL4172587

CCN(C(=O)O)c1ccc(F)cn1

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HCAR3 P49019 2/20 0.40
HTT P42858 2/20 0.37
HDAC1 Q13547 4/20 0.37
TSHR P16473 2/20 0.37
ALDH1A1 P00352 1/20 0.37
GLA P06280 1/20 0.37
GRIN1 Q05586 1/20 0.36
GRIN2A Q12879 1/20 0.36
GRM1 Q13255 1/20 0.36
PTGIR P43119 1/20 0.36
POLB P06746 1/20 0.36
CACNA1H O95180 1/20 0.36
PTGDR2 Q9Y5Y4 1/20 0.35
ALOX15 P16050 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
GBA1 P04062 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4782065 0.87 HDAC1 (0.37) HCAR3HDAC1ALDH1A1GRIN1GRIN2A
SCHEMBL3718183 0.87 HDAC1 (0.37) HCAR3HDAC1TSHRALDH1A1GLA
SCHEMBL6027792 0.78 ALDH1A1 (0.45) HTTTSHRALDH1A1GLAPOLB
SCHEMBL1117875 0.78 HCAR3 (0.48) HCAR3HTTTSHRALDH1A1POLB
SCHEMBL15173773 0.77 HCAR3 (0.38) HCAR3HDAC1GRM1PTGIRPTGDR2
SCHEMBL5508940 0.74 POLB (0.60) HTTTSHRALDH1A1GLAPOLB
SCHEMBL4023870 0.73 HCAR3 (0.39) HCAR3HDAC1ALDH1A1GRIN1GRIN2A
SCHEMBL4736030 0.72 CACNA1H (0.47) TSHRALDH1A1CACNA1HGBA1
SCHEMBL22518408 0.70 TSHR (0.41) HTTTSHRALDH1A1GLAPOLB
SCHEMBL19714338 0.70 PTGIR (0.52) HTTHDAC1ALDH1A1PTGIRPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009013545-A2 CHEMICAL COMPOUNDS ASTRAZENECA AB (SE) 2009-01-29 WO disclosed
WO-2008132502-A1 PYRAZOLYL-AMINO-SUBSTITUTED PYRIMIDINES AND THEIR USE FOR THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2008-11-06 WO disclosed